GlassScriptPhysician profile
Kevin Zhang
NPI 1861066797
$1,427.18
in general payments reported to CMS, 2019-2025
13 companies · $398 in 2025
The $398 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $36.74 · 2023: $527 · 2024: $466 · 2025: $398.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,390.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $563.50 | 2023-2025 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $288.01 | 2023 | Breztri, Farxiga |
| Lilly USA, LLC | $141.71 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Phadia US INC. | $112.28 | 2023-2025 | Immunocap |
| Hologic Sales and Service, LLC | $69.99 | 2022-2025 | Thinprep 2000 Processor, Aptima |
| Merck Sharp & Dohme LLC | $58.33 | 2024-2025 | Gardasil 9, Capvaxive, Gardasil |
| Cranial Technologies, INC | $52.99 | 2024-2025 | Doc Band |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.71 | 2024 | Jardiance |
| Organon LLC | $20.49 | 2025 | Nexplanon |
| Alkermes, INC. | $19.96 | 2024 | Vivitrol |
| Biohaven Pharmaceutical Holding Company LTD. | $19.19 | 2022 | |
| Dexcom, INC. | $17.25 | 2025 | Dexcom G6 Transmitter |
| Cipher Pharmaceuticals US LLC | $13.77 | 2025 | Natroba, Spinosad |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Zhang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.